Connect with us

Technology

AI-Based Medical Diagnostic Tools Market Set to Exceed USD 11.5 Billion by 2034: Global Surge in AI Start-up Funding Expands Diagnostic Systems Integration | TMR

Published

on

AI-powered diagnostic systems deliver precise and efficient diagnoses, enabling healthcare professionals to develop timely and effective treatment plans. This integration of AI extends across various diagnostic tools, including X-rays, enhancing their capabilities on a broader scale.

WILMINGTON, Del., July 17, 2024 /PRNewswire/ — The market for AI-based medical diagnostic tools accounted for US$ 1.3 billion in 2023. A CAGR of 20.8% is expected from 2024 to 2034, culminating in a market value of US$ 11.5 billion by 2034. Medical diagnostic instruments based on AI require ongoing research and development.

In addition to enhancing the efficiency of existing algorithms, this involves investigating new artificial intelligence approaches such as deep learning, reinforcement learning, and federated learning for medical applications.

AI-based diagnostic tools can empower patients by providing them with personalized health information. Smartphone apps and AI-driven health monitoring gadgets can help patients manage their health and well-being more actively.

Medical specialists and facilities are often limited in underserved or distant places, so AI-based diagnostics can be especially helpful. Through the use of portable diagnostic devices and telemedicine platforms, Artificial Intelligence can increase access to healthcare for communities that have limited access to healthcare.

Grab Your Sample Report Here! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=69867

Healthcare systems are expected to incorporate AI-based diagnostic technologies as they advance in sophistication and dependability. This integration may include seamless integration with clinical decision support systems and electronic health records (EHR) in order to speed up diagnosis for healthcare practitioners.

Key Findings of the Market Report

AI-based medical diagnostic tools will be created in the market by the software segment.As consumers become more likely to suffer from cancer, demand for oncology AI-based medical diagnostics tools will increase.In 2023, diagnostic laboratories held the largest share of the market.In 2023, North America dominated the market in terms of market share.

Global AI-based Medical Diagnostic Tools Market: Growth Drivers

Increasing chronic illness prevalence and an expanding need for accurate and timely diagnosis are two contributing factors. With AI-powered diagnostic tools, health care providers can detect diseases earlier and treat them more effectively, thus improving their accuracy, efficiency, and speed of diagnosis. Diabetes, cancer, and cardiovascular diseases are a few of the chronic diseases that have increased the need for novel diagnostic methods.AI-based diagnostic tools are becoming easier to incorporate into clinical practice as electronic health records (EHRs) become more widely adopted and data access increases.AI algorithms are being assessed and trained using substantial amounts of patient data by healthcare organizations and providers. As a result, diagnostic instruments that are more reliable and beneficial therapeutically are being developed.The healthcare sector is also embracing AI-based diagnostic tools on a larger scale as regulatory agencies become more aware of its potential to improve patient outcomes and reduce healthcare costs.As a result, AI-based medical diagnostics have a lot of potential for improving the accuracy, efficiency, and personalized treatment of patients, so they’re a great fit for the future.

Get a PDF Brochure for Report Overview! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=69867

AI-based Medical Diagnostic Tools Market Report Scope:

Report Coverage

Details 

Forecast Period  

2024-2034

Base Year  

2020-2022

Size in 2023

US$ 1.3 Bn

Forecast (Value) in 2034

US$ 11.5 Bn

Growth Rate (CAGR) 

20.8 %

No. of Pages 

156 Pages 

Segments covered 

By Component, By Application, By Region, By End-user

Global AI-based Medical Diagnostic Tools Market: Regional Landscape

Artificial intelligence-based medical diagnostic technologies are undergoing rapid scientific advancements in North America. AI-driven diagnostic technology is gradually being integrated into clinical operations in the area in order to improve patient outcomes and increase productivity.Regulatory agencies like Health Canada and the Food and Drug Administration (FDA) in the United States and Canada approve and oversee medical devices and diagnostic tools. The development of AI-based diagnostics in the future will be influenced by the way these regulatory bodies adapt their approval procedures to take into account the rapidly developing AI technologies while maintaining patient safety and efficacy.In North America, regulatory agencies such as the Food and Drug Administration (FDA) are essential to guaranteeing the security and efficacy of medical diagnostic devices powered by artificial intelligence (AI). To help businesses launch their products while maintaining patient safety and data security, the FDA has set guidelines for the validation and oversight of AI algorithms used in medical diagnostics. Because of this, North America continues to lead the way in AI-driven innovation in medical diagnostics, and further growth and adoption are anticipated.

Global AI-based Medical Diagnostic Tools Market: Competitive Landscape

AI-based medical diagnostic tool companies are expanding their customer bases through inorganic expansion. Brain tumors can be accurately detected by AI-based tools developed by medical diagnostic companies.

Key Players Profiled

MicrosoftNvidia CorporationMerative L.P.Alphabet Inc.Intel CorporationSiemens HealthineersGE HealthCareAdvanced Micro Devices Inc.Koninklijke Philips N.V.InformAI

Key Developments

In October 2023, Microsoft launched new data and artificial intelligence solutions for healthcare organizations to unlock insights and improve patient care.In December 2023, Nvidia launched a series of cloud APIs that accelerate AI model development and deployment for medical imaging applications. Using Nvidia’s open-source Monai framework, the new offering extends Monai with cloud-native capabilities.

Global AI-based Medical Diagnostic Tools Market: Segmentation

By Component

SoftwareServicesHardwareMemoryOthers (Network, etc.)

By Application

RadiologyCardiologyNeurologyOncologyOthers (Ophthalmology, Gynecology, etc.)

By End User

HospitalsDiagnostic LaboratoriesOthers (Ambulatory Surgical Centers, etc.)

By Region

North AmericaEuropeAsia PacificLatin AmericaMiddle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=69867&ltype=S

More Trending Reports by Transparency Market Research –

X-ray Detectors Market – The global market was worth US$ 2.5 Bn and is projected to reach a value of US$ 4.6 Bn by the end of 2031

Electronic Health Records (EHR) Market – The global market is forecasted to experience robust growth, reaching over US$ 48.3 billion by 2031, with a projected CAGR of 6.5% from 2023 onwards.

 Digital Biomarkers Market: Digital Biomarkers Market is expected to grow at a CAGR of 31.4% from 2024 to 2034 and reach US$ 43.3 Bn by the end of 2034

Clinical Data Analytics Market: Clinical Data Analytics Market is expected to grow at a CAGR of 39.7% from 2024 to 2034 and reach US$ 614.7 Bn by the end of 2034

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/ai-based-medical-diagnostic-tools-market-set-to-exceed-usd-11-5-billion-by-2034-global-surge-in-ai-start-up-funding-expands-diagnostic-systems-integration–tmr-302199301.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Paratus granted regulatory approval for renewable power industry

Published

on

By

Paratus to write the world’s first policy for renewable power price protection

GUERNSEY and LONDON, Sept. 25, 2024 /PRNewswire/ — Paratus Holdings Limited (“Paratus”), the world’s first (re)insurance group underwriting energy price risk, today announces that Paratus Renewables Insurance Limited has been granted regulatory approval by the Guernsey Financial Services Authority (“GFSC”) to provide insurance cover to the renewable power industry.

Paratus provides innovative and commercially viable insurance solutions to accelerate the transition to renewable energy and sustainable fuels. The licence approval will expand the product offering beyond aviation, maritime, and freight to renewable power including wind, solar, biofuels, and hydrogen.

Paratus renewable power insurance protects generators from adverse energy price risk, improving the competitiveness of renewable assets when compared to traditional price risk mitigation solutions. Equally, their policies enable power consumers to better manage operating costs and protect balance-sheets in a highly opaque marketplace. Through a deep understanding of the renewables energy sector, Paratus partners with clients to navigate a complex energy market.

The regulatory approval by the GFSC marks another significant milestone for the business. In January 2023, Paratus announced the completion of a growth equity investment from Ara Partners (“Ara”), a global private equity and infrastructure firm focused on industrial decarbonisation. The Ara investment has provided the capital required for Paratus to significantly scale and enhance the product offering.

Gus Majed, Group CEO and Founder, Paratus, commented: “The renewable power licence is central to our future growth. We are writing the world’s first policy for renewable power price protection and our product will have a transformative impact on the renewable energy industry. It will help catalyse the growth and competitiveness of renewable power assets, as Paratus expands across the U.K., Europe and the U.S.

Our focus is on providing clear, simple and transparent solutions that transform how firms mitigate adverse energy price volatility. This is a crucial step forward for the business and for the industry, as our world first renewable power price insurance policy will accelerate the transition to renewable energy sources and sustainable fuels.”

Paratus has further enhanced its offering by partnering with px Group, a fully licenced Ofgem supply business that provides power balancing capabilities. This partnership enables Paratus & Partners, the Group’s insurance brokerage division, to leverage px Group’s capability to provide Paratus and clients with compelling economics for physical offtake and 24/7 monitoring services, when they take out an insurance policy.

Gus added: “px Group has long standing experience and a first-class reputation for working with customers in the renewable energy space, and we are confident that this strategic partnership will help to support renewable power producers even more effectively, as they drive the transition to net zero. With px Group, we can deliver an end-to-end complete solution for renewable power generators.”

About Paratus

Paratus is the world’s first (re)insurer underwriting energy price risk with innovative solutions to protect against adverse energy price volatility and accelerate the transition to net-zero. A unique partnership of world-class experts in energy, insurance, and technology, Paratus is backed by Ara Partners, a $6.2 billion global private equity and infrastructure firm focused on industrial decarbonisation, and underwritten by globally rated financial institutions.

About px Group

px Group is a fully integrated infrastructure solutions business delivering innovative management services for high hazard and highly regulated environments. px Group manages, operates and maintains some of the largest industrial facilities in the UK and in Norway, and owns the world-renowned Saltend Chemicals Park at the heart of the UK’s Energy Estuary. 

With over 25 years’ experience, and operations in the UK, Norway, Germany and the Americas, px Group delivers end-to-end specialist services in operations & maintenance, engineering services and energy solutions across the industrial and energy infrastructure sectors. 

About Ara Partners 

Ara Partners is a global private equity and infrastructure investment firm focused on industrial decarbonization. Founded in 2017, Ara Partners seeks to build and scale companies with significant decarbonization impact across the industrial and manufacturing, chemicals and materials, energy efficiency and green fuels, and food and agriculture sectors. The company operates from offices in Houston, Boston, Washington, D.C., and Dublin. Ara Partners closed its third private equity fund in December 2023 with over $2.8 billion in capital commitments. As of March 31, 2024, Ara Partners had approximately $6.2 billion of assets under management. For more information about Ara Partners, please visit www.arapartners.com.

Media contacts 

Kapil Arya / Ed Shelley
Lansons
paratus@lansons.com
07550044000

View original content:https://www.prnewswire.co.uk/news-releases/paratus-granted-regulatory-approval-for-renewable-power-industry-302258109.html

Continue Reading

Technology

Zumo helps crypto-asset service providers breathe easier ahead of deadline for MiCA sustainability disclosures

Published

on

By

EDINBURGH, Scotland and LONDON, Sept. 25, 2024 /PRNewswire/ — Zumo, the B2B digital assets infrastructure, has launched a new out-of-box feature that enables crypto-asset service providers (CASPs) active in the European Union (EU) to comply with the upcoming sustainability requirements of the Markets in Crypto-Assets (MiCA) regulation.

Recent industry research has suggested that more than 80% of CASPs may be unaware of the need to report sustainability indicators from ESMA’s end-of-year deadline.

Under new rules, CASPs with a EU client footprint – including exchanges, brokerages, custodians and trading firms – will need to provide a compliant website disclosure covering the environmental impact of offered crypto-assets from 30 December 2024.

Amidst a flurry of incoming requirements, Zumo’s new Oxygen MiCA compliance module will help CASPs across the EU to streamline and simplify their sustainability compliance through auto-generated MiCA website disclosure reports, and allows CASPs to easily access MiCA-compliant sustainability metrics for their listed crypto-assets.

The solution draws on best-in-class sustainability data from Crypto Carbon Ratings Institute (CCRI), one of Zumo’s strategic partners, and further builds on Zumo’s Oxygen proposition, first introduced to help providers of crypto-asset services better align their digital asset activities with net zero principles. 

Nick Jones, Founder and CEO, Zumo, said: “MiCA’s sustainability requirements are going live to a tight deadline, and bring with them complex data questions and unfamiliar compliance requirements at a time when the industry is already having to confront a wide range of new operational mandates.”

“It’s become clear that CASPs across Europe simply aren’t ready. With our MiCA solution, we’re removing one small headache by providing the single interface that helps CASPs cut through the hassle of pulling sustainability data together, formatting an appropriate template, and providing the output that ESMA is looking for.”

“It’s another important step on our sustainability journey to develop the tools that will enable service providers to comply with current and future sustainability compliance requirements.”

Zumo is widely seen as a pioneer for its sustainability work in the digital assets sphere. The company was a member of the World Economic Forum’s Crypto Sustainability Coalition, recently signed the Abu Dhabi Sustainable Finance Declaration and has been recognised via a number of prestigious awards programmes.

Logo – https://mma.prnewswire.com/media/2514072/Zumo_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/zumo-helps-crypto-asset-service-providers-breathe-easier-ahead-of-deadline-for-mica-sustainability-disclosures-302257412.html

Continue Reading

Technology

Mencom Strengthens European Presence with New Sales Office in the Netherlands

Published

on

By

OAKWOOD, Ga. and ALMELO, Netherlands, Sept. 25, 2024 /PRNewswire/ — Mencom Corporation, a global manufacturer of industrial connector solutions for power, control, signal and networking applications, has announced the opening of its new sales office in the Netherlands. This strategic move highlights Mencom’s dedication to serving its expanding customer base and distribution partners throughout the European Union.

The new Dutch office will function as a central hub for sales activities, product demonstrations, training sessions and client meetings. A dedicated team of sales professionals versed in Mencom’s product portfolio will offer tailored support and guidance to customers across the region.

“Our investment in a European sales presence allows us to better serve our customers and meet increasing demand for Mencom’s innovative solutions,” said Bruce Mistarz, CEO of Mencom Corporation. “With this expansion, we reinforce our position as a trusted partner delivering exceptional value to the European market.”

In conjunction with their acquisition of a manufacturing facility in the Czech Republic, this new Dutch office aims to streamline operations and ensure prompt product delivery across Europe. Plus, customers can anticipate service with local product availability and quicker response times. The company is committed to strengthening its presence in Europe while maintaining its commitment to customer satisfaction.

For any questions regarding Mencom’s new office in Europe, products, or customer support, please contact the following:

Mencom Europe
Windmolen 22
7609NN Almelo
The Netherlands

http://www.mencomcorp.eu
+31 548 659 054
europe@mencomcorp.eu

For details, contact:
Mark Dixon
Marketing Manager
Email: mark@mencom.com
Phone: (770)534-4585

Photo – https://mma.prnewswire.com/media/2514424/Mencom_Corporation_New_sales_office.jpg
Logo – https://mma.prnewswire.com/media/2338182/Mencom_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/mencom-strengthens-european-presence-with-new-sales-office-in-the-netherlands-302257706.html

Continue Reading

Trending